Sighinolfi L - Search Results

1

Anti-Tat immunity defines CD4⁺ T-cell dynamics in people living with HIV on long-term cART.

Tripiciano A, Picconi O, Moretti S, Sgadari C, Cafaro A, Francavilla V, Arancio A, Paniccia G, Campagna M, Pavone-Cossut MR, Sighinolfi L, Latini A, Mercurio VS, Pietro MD, Castelli F, Saracino A, Mussini C, Perri GD, Galli M, Nozza S, Ensoli F, Monini P, Ensoli B. Tripiciano A, et al. Among authors: sighinolfi l. EBioMedicine. 2021 Apr;66:103306. doi: 10.1016/j.ebiom.2021.103306. Epub 2021 Apr 7. EBioMedicine. 2021. PMID: 33839064 Free PMC article.

2

Human herpesviruses 6 and 7 in salivary glands and shedding in saliva of healthy and human immunodeficiency virus positive individuals.

Di Luca D, Mirandola P, Ravaioli T, Dolcetti R, Frigatti A, Bovenzi P, Sighinolfi L, Monini P, Cassai E. Di Luca D, et al. Among authors: sighinolfi l. J Med Virol. 1995 Apr;45(4):462-8. doi: 10.1002/jmv.1890450418. J Med Virol. 1995. PMID: 7666047

3

Selection of antiretroviral therapy guided by genotypic or phenotypic resistance testing: an open-label, randomized, multicenter study (PhenGen).

Saracino A, Monno L, Locaputo S, Torti C, Scudeller L, Ladisa N, Antinori A, Sighinolfi L, Chirianni A, Mazzotta F, Carosi G, Angarano G. Saracino A, et al. Among authors: sighinolfi l. J Acquir Immune Defic Syndr. 2004 Dec 15;37(5):1587-98. doi: 10.1097/00126334-200412150-00011. J Acquir Immune Defic Syndr. 2004. PMID: 15577415 Clinical Trial.

4

CD4 cell-monitored treatment interruption in patients with a CD4 cell count > 500 x 106 cells/l.

Mussini C, Bedini A, Borghi V, Guaraldi G, Esposito R, Barchi E, Enilia R, Cozzi-Lepri A, Philips AN, Ortolani P, Bratt G, Eriksson LE, Sighinolfi L, Cossarizza A, d'Arminio Monforte A, De Luca A, Di Giambenedetto S, Antinori A; International Study Group on CD4-monitored Treatment Interruptions. Mussini C, et al. Among authors: sighinolfi l. AIDS. 2005 Feb 18;19(3):287-94. AIDS. 2005. PMID: 15718839

5

Predictors of AIDS-defining events among advanced naïve patients after HAART.

Torti C, Lapadula G, Maggiolo F, Casari S, Suter F, Minoli L, Pezzoli C, Pietro MD, Migliorino G, Quiros-Roldan E, Ladisa N, Sighinolfi L, Gatti F, Carosi G; Italian MASTER Cohort. Torti C, et al. Among authors: sighinolfi l. HIV Clin Trials. 2007 May-Jun;8(3):112-20. doi: 10.1310/hct0803-112. HIV Clin Trials. 2007. PMID: 17621458

6

Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.

Lapadula G, Torti C, Maggiolo F, Casari S, Suter F, Minoli L, Pezzoli C, Di Pietro M, Migliorino G, Ouiros-Roldan E, Ladisa N, Sighinolfi L, Costarelli S, Carosi G; Italian MASTER Cohort. Lapadula G, et al. Among authors: sighinolfi l. Antivir Ther. 2007;12(6):941-7. Antivir Ther. 2007. PMID: 17926648

7

Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.

Saracino A, Gianotti N, Marangi M, Cibelli DC, Galli A, Punzi G, Monno L, Lazzarin A, Angarano G; Mutations, Salvage Study Group. Saracino A, et al. J Med Virol. 2008 Oct;80(10):1695-706. doi: 10.1002/jmv.21261. J Med Virol. 2008. PMID: 18712823

8

Patients presenting with AIDS in the HAART era: a collaborative cohort analysis.

Mussini C, Manzardo C, Johnson M, Monforte Ad, Uberti-Foppa C, Antinori A, Gill MJ, Sighinolfi L, Borghi V, Lazzarin A, Miró JM, Sabin C; Late Presenter Investigators. Mussini C, et al. Among authors: sighinolfi l. AIDS. 2008 Nov 30;22(18):2461-9. doi: 10.1097/QAD.0b013e328314b5f1. AIDS. 2008. PMID: 19005269

9

Magnitude and determinants of CD4 recovery after HAART resumption after 1 cycle of treatment interruption.

Mussini C, Touloumi G, Bakoyannis G, Sabin C, Castagna A, Sighinolfi L, Erikson LE, Bratt G, Borghi V, Lazzarin A, Cossarizza A, Esposito R. Mussini C, et al. Among authors: sighinolfi l. J Acquir Immune Defic Syndr. 2009 Dec;52(5):588-94. doi: 10.1097/qai.0b013e3181b9e94d. J Acquir Immune Defic Syndr. 2009. PMID: 19950432

10

One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects.

Airoldi M, Zaccarelli M, Bisi L, Bini T, Antinori A, Mussini C, Bai F, Orofino G, Sighinolfi L, Gori A, Suter F, Maggiolo F. Airoldi M, et al. Among authors: sighinolfi l. Patient Prefer Adherence. 2010 May 13;4:115-25. doi: 10.2147/ppa.s10330. Patient Prefer Adherence. 2010. PMID: 20517472 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

204 results

Search Page